Extracellular regulation of VEGF: isoforms, proteolysis, and vascular patterning P Vempati, AS Popel, F Mac Gabhann Cytokine & growth factor reviews 25 (1), 1-19, 2014 | 384 | 2014 |
Where is VEGF in the body? A meta-analysis of VEGF distribution in cancer C Kut, F Mac Gabhann, AS Popel British journal of cancer 97 (7), 978-985, 2007 | 365 | 2007 |
A systems biology perspective on sVEGFR1: its biological function, pathogenic role and therapeutic use FTH Wu, MO Stefanini, FM Gabhann, CD Kontos, BH Annex, AS Popel Journal of cellular and molecular medicine 14 (3), 528-552, 2010 | 278 | 2010 |
A systems biology view of blood vessel growth and remodelling EA Logsdon, SD Finley, AS Popel, FM Gabhann Journal of cellular and molecular medicine 18 (8), 1491-1508, 2014 | 264 | 2014 |
Systems biology of vascular endothelial growth factors FM Gabhann, AS Popel Microcirculation 15 (8), 715-738, 2008 | 260 | 2008 |
Multiscale models of angiogenesis AA Qutub, F Mac Gabhann, ED Karagiannis, P Vempati, AS Popel IEEE engineering in medicine and biology magazine 28 (2), 14-31, 2009 | 200 | 2009 |
A compartment model of VEGF distribution in blood, healthy and diseased tissues MO Stefanini, FTH Wu, F Mac Gabhann, AS Popel BMC systems biology 2, 1-25, 2008 | 188 | 2008 |
Design principles for therapeutic angiogenic materials PS Briquez, LE Clegg, MM Martino, FM Gabhann, JA Hubbell Nature Reviews Materials 1 (1), 1-15, 2016 | 186 | 2016 |
Dimerization of VEGF receptors and implications for signal transduction: a computational study F Mac Gabhann, AS Popel Biophysical chemistry 128 (2-3), 125-139, 2007 | 175 | 2007 |
Model of competitive binding of vascular endothelial growth factor and placental growth factor to VEGF receptors on endothelial cells F Mac Gabhann, AS Popel American Journal of Physiology-Heart and Circulatory Physiology 286 (1 …, 2004 | 175 | 2004 |
Brain macrophages in simian immunodeficiency virus-infected, antiretroviral-suppressed macaques: a functional latent reservoir CR Avalos, CM Abreu, SE Queen, M Li, S Price, EN Shirk, EL Engle, ... MBio 8 (4), 10.1128/mbio. 01186-17, 2017 | 147 | 2017 |
Systems biology of pro‐angiogenic therapies targeting the VEGF system F Mac Gabhann, AA Qutub, BH Annex, AS Popel Wiley Interdisciplinary Reviews: Systems Biology and Medicine 2 (6), 694-707, 2010 | 116 | 2010 |
Collateral capillary arterialization following arteriolar ligation in murine skeletal muscle FM Gabhann, SM Peirce Microcirculation 17 (5), 333-347, 2010 | 113 | 2010 |
Differential binding of VEGF isoforms to VEGF receptor 2 in the presence of neuropilin-1: a computational model F Mac Gabhann, AS Popel American Journal of Physiology-Heart and Circulatory Physiology 288 (6 …, 2005 | 110 | 2005 |
VEGF gradients, receptor activation, and sprout guidance in resting and exercising skeletal muscle F Mac Gabhann, JW Ji, AS Popel Journal of applied physiology 102 (2), 722-734, 2007 | 109 | 2007 |
Interactions of VEGF isoforms with VEGFR-1, VEGFR-2, and neuropilin in vivo: a computational model of human skeletal muscle FM Gabhann, AS Popel American Journal of Physiology-Heart and Circulatory Physiology 292 (1 …, 2007 | 105 | 2007 |
Computational model of vascular endothelial growth factor spatial distribution in muscle and pro-angiogenic cell therapy F Mac Gabhann, JW Ji, AS Popel PLoS computational biology 2 (9), e127, 2006 | 96 | 2006 |
Quantifying the proteolytic release of extracellular matrix-sequestered VEGF with a computational model P Vempati, F Mac Gabhann, AS Popel PloS one 5 (7), e11860, 2010 | 95 | 2010 |
Increase of plasma VEGF after intravenous administration of bevacizumab is predicted by a pharmacokinetic model MO Stefanini, FTH Wu, F Mac Gabhann, AS Popel Cancer Research 70 (23), 9886-9894, 2010 | 92 | 2010 |
Module-based multiscale simulation of angiogenesis in skeletal muscle G Liu, AA Qutub, P Vempati, F Mac Gabhann, AS Popel Theoretical Biology and Medical Modelling 8, 1-26, 2011 | 91 | 2011 |